A549 |
Adenocarcinomic human alveolar basal epithelial cells |
ABL |
Tyrosine-protein kinase transforming protein Abl |
ABCB1/Flp-In™-293 |
Fetal kidney cell line stably expressing P-gp |
ABVD |
Chemotherapy with doxorubicin, bleomycin, vinblastine, and dacarbazine |
BCR |
Breakpoint cluster region protein (renal carcinoma antigen NY-REN-26) |
BEACOPP |
Chemotherapy combination of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisolone |
CHOP |
Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone |
CNS |
Central nervous system |
CVD |
Chemotherapy with cyclophosphamide, vincristine, and dacarbazine |
DNA |
Deoxyribonucleic acid |
Eca109/VCR |
Human cells from esophageal cancer |
EPOCH-(R) |
Combination therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, rituximab, and etoposide |
EMA |
Chemotherapy combination of methotrexate, etoposide, and dactinomy-cin |
EMA/CO |
Chemotherapy combination of etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine |
FDA |
US Food and Drug Administration |
G401 |
Human cells from a rhabdoid tumor of the kidney |
IC50
|
Half-maximal inhibitory concentration |
IDH1/2
|
Gene encoding nicotinamide adenine dinucleotide phosphate-dependent isocitrate dehydrogenases |
IL-1 |
Interleukin 1 receptor |
KB-V |
Cervical adenocarcinoma cell line |
LGG |
Low-grade gliomas |
LC3-I |
Microtubule-associated proteins 1A/1B light chain 3B |
lncRNA |
Long non-coding RNA |
MCF-7/ADR |
Multidrug-resistant breast cancer cell line |
MEG3
|
Maternally expressed gene 3 |
MOPP |
Combination of vincristine, procarbazine, prednisone, and mechlorethamine |
NHP2L1 |
Non-histone protein 2-like protein 1 |
NOXA
|
Gene coding phorbol-12-myristate-13-acetate-induced protein 1 |
PCNSL |
Primary central nervous system lymphoma |
PCV |
Chemotherapy combination of procarbazine, lomustine, and vincristine |
P-gp |
P-glycoprotein |
PMAIP1
|
Gene encoding phorbol-12-myristate-13-acetate-induced protein 1 |
R-CHOP |
Combination therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab |
R-CHOPE |
Combination therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, rituximab, and etoposide |
RNA |
Ribonucleic acid |
VIPN |
Vincristine-induced peripheral neuropathy |
WERI-Rb-1 |
Human cells from retinoblastoma |
XIST |
X-inactive specific transcript |
Y79 |
Human cells from retinoblastoma |